Nifty

:

18114.90

Sensex

:

60821.62

-63.20 (-0.35%)
-101.88 (-0.17%)

Login

Nifty
Sensex

:
:

18114.90
60821.62

-63.20 (-0.35%)
-101.88 (-0.17%)

Pfizer Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

54/99

BSE: 500680 | NSE: PFIZER

Watchlist

NSE BSE

5153.75

22-Oct-2021

Open
High
Low
Previous Close

5201.00
5264.65
5140.00
5212.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

16381
850.98
6175.00
4330.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

23,592.11
41.17
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

22,479.51
0.68%
9.10

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.43
2.63
2.45

EBITDA CAGR (%)

10 Years
5 Years
3 Years

13.73
15.27
4.72

PAT CAGR (%)

10 Years
5 Years
3 Years

10.42
8.12
5.07

P:E (Median)

8 Years
5 Years
3 Years

35.22
34.01
37.83

P:BV (Average)

8 Years
5 Years
3 Years

8.51
8.51
8.51

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.01
19.76
22.44

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 749.17 514.89 45.50% 534.76 502.01 6.52% 593.49 538.18 10.28% 595.41 567.06 5.00%
Expenses 463.43 328.60 41.03% 409.02 393.30 4.00% 396.72 404.74 -1.98% 392.09 402.88 -2.68%
EBITDA 285.74 186.29 53.38% 125.74 108.71 15.67% 196.77 133.44 47.46% 203.32 164.18 23.84%
EBIDTM 38.14% 36.18% 23.51% 21.65% 33.15% 24.79% 34.15% 28.95%
Other Income 12.24 17.20 -28.84% 37.20 45.22 -17.74% 14.57 58.22 -74.97% 12.15 44.75 -72.85%
Interest 2.25 3.01 -25.25% 3.54 3.62 -2.21% 3.85 2.46 56.50% 4.71 2.62 79.77%
Depreciation 27.00 27.14 -0.52% 27.31 28.41 -3.87% 27.23 24.70 10.24% 27.73 25.13 10.35%
PBT 268.73 173.34 55.03% 132.09 121.90 8.36% 180.26 164.50 9.58% 183.03 181.18 1.02%
Tax 68.82 48.89 40.76% 31.54 18.89 66.97% 39.02 25.44 53.38% 51.66 26.93 91.83%
PAT 199.91 124.45 60.63% 100.55 103.01 -2.39% 141.24 139.06 1.57% 131.37 154.25 -14.83%
PATM 26.68% 24.17% 18.80% 20.52% 23.80% 25.84% 22.06% 27.20%
EPS 43.74 27.23 60.63% 22.00 22.54 -2.40% 30.91 30.43 1.58% 28.75 33.75 -14.81%

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 2,472.83 2,238.55 2,151.65 2,081.50 1,968.51 1,966.26 2,012.34 1,853.32 1,111.81 1,048.84 1,093.29 Net Sales Growth 16.53% 4.04% 3.37% 5.74% 0.11% -2.29% 8.58% 66.69% 6.00% -4.07% Cost Of Goods Sold 894.67 734.29 741.69 678.48 677.55 711.67 698.85 649.77 305.51 270.02 290.09 Gross Profit 1,578.16 1,504.26 1,409.96 1,403.02 1,290.96 1,254.59 1,313.49 1,203.55 806.30 778.83 803.19 GP Margin 63.82% 67.20% 65.53% 67.40% 65.58% 63.81% 65.27% 64.94% 72.52% 74.26% 73.47% Total Expenditure 1,661.26 1,526.15 1,578.93 1,515.87 1,467.87 1,616.13 1,579.46 1,473.98 872.54 864.68 896.48 Power & Fuel Cost - 5.79 11.04 11.45 12.34 10.34 10.43 10.40 8.62 8.61 9.07 % Of Sales - 0.26% 0.51% 0.55% 0.63% 0.53% 0.52% 0.56% 0.78% 0.82% 0.83% Employee Cost - 361.06 364.51 323.84 314.29 303.89 277.34 236.36 191.77 211.12 192.82 % Of Sales - 16.13% 16.94% 15.56% 15.97% 15.46% 13.78% 12.75% 17.25% 20.13% 17.64% Manufacturing Exp. - 123.71 104.97 131.96 118.74 151.54 153.84 162.31 124.18 118.58 125.03 % Of Sales - 5.53% 4.88% 6.34% 6.03% 7.71% 7.64% 8.76% 11.17% 11.31% 11.44% General & Admin Exp. - 128.70 165.96 182.49 173.38 234.11 207.63 202.62 124.64 126.94 127.91 % Of Sales - 5.75% 7.71% 8.77% 8.81% 11.91% 10.32% 10.93% 11.21% 12.10% 11.70% Selling & Distn. Exp. - 137.87 153.70 152.83 143.35 152.82 168.00 156.82 87.83 100.10 122.93 % Of Sales - 6.16% 7.14% 7.34% 7.28% 7.77% 8.35% 8.46% 7.90% 9.54% 11.24% Miscellaneous Exp. - 34.73 37.06 34.82 28.22 51.76 63.38 55.71 29.98 29.32 122.93 % Of Sales - 1.55% 1.72% 1.67% 1.43% 2.63% 3.15% 3.01% 2.70% 2.80% 2.62% EBITDA 811.57 712.40 572.72 565.63 500.64 350.13 432.88 379.34 239.27 184.16 196.81 EBITDA Margin 32.82% 31.82% 26.62% 27.17% 25.43% 17.81% 21.51% 20.47% 21.52% 17.56% 18.00% Other Income 76.16 81.12 184.02 167.39 114.29 101.16 86.99 71.72 109.38 105.24 92.73 Interest 14.35 15.39 11.01 1.72 0.77 1.96 1.40 1.51 1.10 1.73 2.08 Depreciation 109.27 109.41 103.24 71.39 66.25 62.93 57.93 131.08 7.97 8.02 9.56 PBT 764.11 668.72 642.49 659.91 547.91 386.40 460.54 318.46 339.58 279.65 277.90 Tax 191.04 171.11 133.36 230.86 187.84 180.05 165.44 137.68 118.73 190.57 92.92 Tax Rate 25.00% 25.59% 20.76% 34.98% 34.28% 34.84% 35.17% 66.36% 34.96% 27.47% 33.48% PAT 573.07 497.61 509.13 429.05 360.07 336.78 304.98 69.82 220.86 503.20 184.61 PAT before Minority Interest 573.07 497.61 509.13 429.05 360.07 336.78 304.98 69.82 220.86 503.20 184.61 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.17% 22.23% 23.66% 20.61% 18.29% 17.13% 15.16% 3.77% 19.86% 47.98% 16.89% PAT Growth 10.04% -2.26% 18.66% 19.16% 6.92% 10.43% 336.81% -68.39% -56.11% 172.57% EPS 125.40 108.89 111.41 93.88 78.79 73.69 66.74 15.28 48.33 110.11 40.40

Description TTM Nov 08 Nov 07 Nov 06 Nov 05
Net Sales - 736.83 736.57 736.33 674.84 Net Sales Growth - 0.04% 0.03% 9.11% Cost Of Goods Sold - 195.94 190.88 186.99 189.67 Gross Profit - 540.89 545.69 549.34 485.17 GP Margin - 73.41% 74.09% 74.61% 71.89% Total Expenditure - 585.58 580.08 570.64 558.84 Power & Fuel Cost - 7.17 7.94 7.50 7.96 % Of Sales - 0.97% 1.08% 1.02% 1.18% Employee Cost - 98.43 98.71 100.37 98.57 % Of Sales - 13.36% 13.40% 13.63% 14.61% Manufacturing Exp. - 92.14 85.84 85.45 80.87 % Of Sales - 12.50% 11.65% 11.60% 11.98% General & Admin Exp. - 49.05 48.30 45.81 45.04 % Of Sales - 6.66% 6.56% 6.22% 6.67% Selling & Distn. Exp. - 99.87 106.89 103.95 96.59 % Of Sales - 13.55% 14.51% 14.12% 14.31% Miscellaneous Exp. - 42.98 41.51 40.57 40.15 % Of Sales - 5.83% 5.64% 5.51% 5.95% EBITDA - 151.25 156.49 165.69 116.00 EBITDA Margin - 20.53% 21.25% 22.50% 17.19% Other Income - 71.10 321.80 33.47 33.24 Interest - 0.00 0.02 0.07 0.16 Depreciation - 11.12 9.58 13.07 13.85 PBT - 211.22 468.69 186.01 135.23 Tax - 119.56 111.34 56.31 41.13 Tax Rate - 28.53% 24.67% 34.62% 36.77% PAT - 299.57 340.00 106.33 70.73 PAT before Minority Interest - 299.57 340.00 106.33 70.73 Minority Interest - 0.00 0.00 0.00 0.00 PAT Margin - 40.66% 46.16% 14.44% 10.48% PAT Growth - -11.89% 219.76% 50.33% EPS - 65.55 74.40 23.27 15.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 2,393.04 3,395.49 3,011.34 2,683.20 2,418.88 2,163.50 1,973.01 658.41 1,694.42 1,304.70 Share Capital 45.75 45.75 45.75 45.75 45.75 45.75 45.75 29.84 29.84 29.84 Total Reserves 2,347.29 3,349.74 2,965.59 2,637.45 2,373.13 2,117.75 1,927.26 628.57 1,664.58 1,274.85 Non-Current Liabilities 85.06 135.93 36.96 52.32 62.41 66.14 -34.97 -19.30 -25.71 -11.26 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 2.50 2.50 0.00 0.00 0.00 Long Term Provisions 55.84 47.87 34.73 37.74 44.85 35.30 29.56 14.79 14.07 25.83 Current Liabilities 774.34 873.36 891.69 954.44 779.67 658.41 608.52 303.38 350.91 251.04 Trade Payables 283.74 426.78 435.92 495.63 388.00 337.92 334.20 159.93 150.59 136.04 Other Current Liabilities 361.47 340.37 294.19 302.29 241.36 181.52 80.59 54.68 39.56 35.64 Short Term Borrowings 2.50 2.50 2.50 2.50 2.50 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 126.63 103.71 159.08 154.02 147.81 138.97 193.72 88.76 160.76 79.36 Total Liabilities 3,252.44 4,404.78 3,939.99 3,689.96 3,260.96 2,888.05 2,546.56 942.49 2,019.62 1,544.48 Net Block 864.74 941.91 853.86 916.60 867.08 924.86 944.34 20.02 25.57 31.49 Gross Block 1,278.52 1,277.00 1,100.27 1,094.86 983.27 980.63 1,288.60 114.83 117.27 118.00 Accumulated Depreciation 413.78 335.09 246.41 178.26 116.19 55.77 344.26 94.81 91.71 86.51 Non Current Assets 1,327.73 1,356.53 1,224.63 1,273.24 1,209.65 1,255.58 1,294.53 256.54 215.24 213.67 Capital Work in Progress 2.76 0.76 0.00 1.04 15.35 3.27 12.56 3.16 0.37 0.38 Non Current Investment 29.56 30.95 32.33 33.72 35.11 36.51 42.66 44.49 45.99 47.50 Long Term Loans & Adv. 275.39 255.26 225.11 236.25 226.29 225.71 294.97 188.87 143.31 134.31 Other Non Current Assets 155.28 127.65 113.33 85.63 65.82 65.23 0.00 0.00 0.00 0.00 Current Assets 1,924.71 3,048.25 2,715.36 2,416.72 2,051.31 1,632.47 1,252.02 685.95 1,804.39 1,330.80 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 Inventories 435.05 430.59 386.66 297.06 321.90 360.68 387.90 151.50 165.15 183.24 Sundry Debtors 129.69 172.03 171.66 154.80 110.32 142.30 160.02 173.39 142.09 141.78 Cash & Bank 1,115.10 2,219.87 1,914.34 1,771.86 1,523.09 1,024.65 609.29 307.79 1,432.94 866.27 Other Current Assets 244.87 199.94 212.90 147.04 96.00 104.85 94.82 53.28 64.21 139.47 Short Term Loans & Adv. 34.66 25.82 29.80 45.96 52.48 57.20 80.52 47.17 43.23 129.83 Net Current Assets 1,150.37 2,174.89 1,823.67 1,462.28 1,271.64 974.06 643.51 382.58 1,453.47 1,079.77 Total Assets 3,252.44 4,404.78 3,939.99 3,689.96 3,260.96 2,888.05 2,546.55 942.49 2,019.63 1,544.47

Description Nov 08 Nov 07 Nov 06 Nov 05
Shareholder's Funds 901.09 649.72 439.76 375.95 Share Capital 29.84 29.84 29.84 29.84 Total Reserves 871.25 619.88 409.91 346.11 Non-Current Liabilities -22.67 -12.98 -14.36 -9.03 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 Current Liabilities 926.36 820.65 696.33 623.95 Trade Payables 108.18 92.43 137.62 120.16 Other Current Liabilities 14.50 14.17 8.14 16.26 Short Term Borrowings 0.00 0.00 0.00 0.00 Short Term Provisions 803.68 714.05 550.57 487.53 Total Liabilities 1,804.78 1,457.39 1,121.73 990.87 Net Block 50.76 60.16 69.96 75.56 Gross Block 139.90 141.61 168.14 170.15 Accumulated Depreciation 89.14 81.45 98.19 94.59 Non Current Assets 83.56 70.91 71.56 77.71 Capital Work in Progress 32.30 10.24 1.60 2.14 Non Current Investment 0.50 0.50 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 Current Assets 1,721.22 1,383.55 1,036.82 876.46 Current Investments 0.00 0.00 0.00 0.00 Inventories 124.99 95.85 99.31 90.71 Sundry Debtors 60.31 61.69 70.10 83.54 Cash & Bank 543.65 479.91 306.94 210.15 Other Current Assets 992.26 8.17 4.22 2.14 Short Term Loans & Adv. 977.77 737.92 556.25 489.92 Net Current Assets 794.86 562.90 340.50 252.52 Total Assets 1,804.78 1,457.39 1,121.72 990.87

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 427.33 323.18 97.81 331.80 328.82 345.48 113.47 132.45 -16.01 24.46 PBT 668.72 642.49 659.91 547.91 516.83 470.42 238.02 339.58 279.65 277.90 Adjustment 54.53 -53.56 -79.47 -32.98 -153.93 -19.53 60.89 -87.82 -84.49 -69.40 Changes in Working Capital -91.78 -52.46 -245.07 10.48 148.91 68.61 -40.42 4.62 -2.91 -61.86 Cash after chg. in Working capital 631.47 536.47 335.37 525.41 511.81 519.51 258.48 256.39 192.25 146.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -204.14 -213.29 -237.56 -193.61 -182.99 -174.03 -145.01 -123.94 -208.26 -121.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 Cash From Investing Activity -468.84 1,530.32 35.12 -238.31 -249.64 -700.87 -88.77 102.66 625.87 277.52 Net Fixed Assets -3.52 -177.49 -4.37 -97.28 -14.72 317.26 -1,183.17 -0.35 0.74 0.95 Net Investments 1.39 1.38 1.39 1.39 1.40 6.15 1.83 1.50 1.56 1.40 Others -466.71 1,706.43 38.10 -142.42 -236.32 -1,024.28 1,092.57 101.51 623.57 275.17 Cash from Financing Activity -1,571.07 -163.52 -109.85 -110.35 -82.59 -61.88 -1.38 -1,360.17 -43.20 -14.13 Net Cash Inflow / Outflow -1,612.58 1,689.98 23.08 -16.86 -3.41 -417.27 23.32 -1,125.06 566.66 287.85 Opening Cash & Equivalents 1,763.79 73.81 50.73 67.59 71.05 488.40 307.86 1,432.92 866.26 578.42 Closing Cash & Equivalent 151.21 1,763.79 73.81 50.73 67.59 71.05 488.40 307.86 1,432.92 866.26

Description Nov 08 Nov 07 Nov 06 Nov 05
Cash From Operating Activity 237.76 16.63 123.19 102.74 PBT 211.22 468.69 186.01 135.23 Adjustment -49.50 -298.40 -8.73 7.24 Changes in Working Capital -7.89 -33.39 11.64 -2.41 Cash after chg. in Working capital 153.83 136.91 188.92 140.06 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -126.90 -113.33 -65.74 -37.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -78.87 232.35 -47.99 -73.08 Net Fixed Assets -20.35 17.89 2.55 Net Investments 0.00 -0.50 0.00 Others -58.52 214.96 -50.54 Cash from Financing Activity -95.20 -75.90 -33.82 -46.02 Net Cash Inflow / Outflow 63.69 173.09 41.38 -16.36 Opening Cash & Equivalents 479.91 306.83 10.00 26.36 Closing Cash & Equivalent 543.61 479.91 51.38 10.00

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 523.07 742.18 658.22 586.49 528.72 472.92 431.28 220.64 567.81 437.21 ROA 13.00% 12.20% 11.25% 10.36% 10.95% 11.22% 4.00% 14.91% 28.24% 12.75% ROE 17.19% 15.89% 15.07% 14.11% 14.70% 14.75% 5.31% 18.77% 33.56% 14.96% ROCE 23.62% 20.38% 23.22% 21.49% 22.62% 22.78% 15.87% 28.96% 46.38% 22.66% Fixed Asset Turnover 1.75 1.81 1.90 1.91 2.08 1.85 2.75 10.04 9.32 9.63 Receivable days 24.60 29.15 28.62 24.43 22.58 26.35 31.59 49.42 47.27 38.93 Inventory Days 70.57 69.32 59.95 57.05 61.01 65.25 51.10 49.61 58.01 55.11 Payable days 87.95 102.95 115.62 121.93 93.70 92.76 62.95 78.13 72.79 55.37 Cash Conversion Cycle 7.22 -4.48 -27.05 -40.45 -10.12 -1.16 19.73 20.89 32.50 38.68 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 44.45 59.36 384.67 712.57 264.69 337.93 138.46 310.56 401.51 134.63

Description Nov 08 Nov 07 Nov 06 Nov 05
Book Value (Rs.) 301.96 216.74 142.90 113.68 ROA 18.37% 26.37% 10.07% 9.39% ROE 38.71% 63.36% 27.78% 22.90% ROCE 54.15% 84.11% 42.50% 35.52% Fixed Asset Turnover 5.62 5.16 4.71 4.43 Receivable days 28.15 30.12 35.19 39.05 Inventory Days 50.96 44.60 43.53 41.49 Payable days 69.16 84.39 92.33 80.44 Cash Conversion Cycle 9.95 -9.68 -13.61 0.09 Total Debt/Equity 0.00 0.00 0.00 0.00 Interest Cover 0.00 0.00 2275.76 712.58

Top Investors:

aditya birla sun life trustee private limited a/c aditya birla sun life bal bhavishya yojna

life insurance corporation of india

Annual Reports:

News Update:

Pfizer enters into business transfer agreement with Mylan Pharmaceuticals
4th Oct 2021, 12:09 PM

The Upjohn Business comprises six brands which include Lyrica, Viagra, Celebrex, Amlogard, Daxid and Dilantin
Read More
Pfizer reports 61% rise in Q1 net profit
28th Jul 2021, 15:24 PM

Total income of the company increased by 43.10% at Rs 761.41 crore for Q1FY22
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback